Sanger sequencing and polymerase chain reaction (PCR) methods have been the standard molecular methods in clinical diagnostics for decades. Next-Generation Sequencing (NGS) technology revolutionized the field of genomics, transcriptomics and metagenomics and is now swiftly becoming a routine method in different areas of clinical diagnostics [1,2].
Vela Diagnostics developed an integrated automated multi-purpose Sentosa® workflow, which consists of:
The combined automated qPCR & NGS Sentosa® workflow is a reliable and efficient in-vitro diagnostics tool for the detection and/or quantitation of a wide range of bacterial and viral pathogens as well as gene mutations. The unique ability of the Sentosa workflow is to provide complete & relevant information to aid clinical decision-making and patient management.
We’ll look at how this single, rapid workflow may be applied to HIV and HCV, delivering accurate genotyping information and in the detection of drug-resistant mutations.
We’ll also see how this workflow is able to deliver actionable oncology results using liquid biopsy samples (cfDNA) with utility in NSCLC, CRC, and BRAF mutation detection.
Research And Development
Medical Laboratory Technician50%
Manufacturer - Other50%